Research and Development

Pulmonary product development in the UK has received a boost following the takeover by biotech company Vectura of the drug …

Merck is to collaborate with traditional medicine company Chi-Med to develop new small molecule anti-cancer drugs from natural products.Chi-Med, based …

Pharma company Sanofi-Aventis has entered into a research agreement with a major French biotech firm to study the role of …

Following the merger deal between German pharma companies Bayer and Schering earlier this year, the new corporation has unveiled radical …

At last, the signals are getting stronger that the biotechnology industry is poised and ready to tackle the publicly quoted …

 AstraZeneca is being forced to conduct a second phase II trial on its sepsis drug, CytoFab.This follows discussions with US, …

American biotech company Novacea says it could be on the brink of revolutionising the prostate cancer market if phase III …

Novartis is to open a major, new pharmaceutical research and development centre in China, becoming the first company in the …

The Department of Health has revised its routine contract for industry-funded NHS clinical trials as a way of improving their …

 A series of problems with GlaxoSmithKline's late stage product pipeline has taken the shine off its third quarter figures.The company …

Back when New Labour was only halfway through its first term of office and when the Millennium Bug was feared …

 CXR Biosciences, based in Scotland, and Artemis Pharmaceuticals in Germany, have been granted licences to sell their genetically modified mice, …

 A drug which had held out the promise of reducing the disabling effects of stroke on patients will be abandoned …

Eli Lilly has opened the first phase of a $560 million expansion to its US biotech research complex.The news comes …

Pfizer will gain entry into the fast-growing vaccines market by buying PowderMed, the British company developing next generation products in …